113 related articles for article (PubMed ID: 34445948)
1. Synergistic Growth Inhibitory Effects of Eryngium kotschyi Extracts with Conventional Cytotoxic Agents: Cisplatin and Doxorubicin against Human Endometrium Cancer Cells.
Karaboğa Arslan AK; Paşayeva L; Esen MA; Tugay O
Curr Pharm Biotechnol; 2022; 23(5):740-748. PubMed ID: 34445948
[TBL] [Abstract][Full Text] [Related]
2. Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells.
Pinmai K; Chunlaratthanabhorn S; Ngamkitidechakul C; Soonthornchareon N; Hahnvajanawong C
World J Gastroenterol; 2008 Mar; 14(10):1491-7. PubMed ID: 18330936
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of Eryngium kotschyi and Eryngium maritimum on Hep2, HepG2, Vero and U138 MG cell lines.
Yurdakök B; Baydan E
Pharm Biol; 2013 Dec; 51(12):1579-85. PubMed ID: 24028780
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effects of 2-methoxyestradiol alone and in combination with chemotherapeutic agents on human endometrial cancer cells.
Chen CH; Lee WJ; Chang TC; Chen RJ; Chien CH; Chow SN
Eur J Gynaecol Oncol; 2009; 30(3):275-80. PubMed ID: 19697620
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the anti-inflammatory and antinociceptive activity of Turkish Eryngium species.
Küpeli E; Kartal M; Aslan S; Yesilada E
J Ethnopharmacol; 2006 Aug; 107(1):32-7. PubMed ID: 16529889
[TBL] [Abstract][Full Text] [Related]
6. Eryngium billardieri Extract and Fractions Induce Apoptosis in Cancerous Cells.
Hasanbeiglu S; Hosseini K; Molavi O; Asgharian P; Tarhriz V
Anticancer Agents Med Chem; 2022; 22(11):2189-2201. PubMed ID: 34852748
[TBL] [Abstract][Full Text] [Related]
7. The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer.
Chitcholtan K; Sykes PH; Evans JJ
J Transl Med; 2012 Mar; 10():38. PubMed ID: 22394685
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
Tyagi AK; Agarwal C; Chan DC; Agarwal R
Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
[TBL] [Abstract][Full Text] [Related]
9. Palmitate Enhances the Efficacy of Cisplatin and Doxorubicin against Human Endometrial Carcinoma Cells.
Wu ZS; Huang SM; Wang YC
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008502
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anti-proliferative activity of Eryngium caucasicum on melanoma cancer cells.
Forouhandeh H; Rezaei Param Z; Molavi O; Asgharian P; Tarhriz V
BMC Complement Med Ther; 2022 May; 22(1):134. PubMed ID: 35568849
[TBL] [Abstract][Full Text] [Related]
11. Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.
Gentilin E; Minoia M; Bondanelli M; Tagliati F; Degli Uberti EC; Zatelli MC
Endocrine; 2017 Jun; 56(3):621-632. PubMed ID: 27585662
[TBL] [Abstract][Full Text] [Related]
12. Oct-4 induces cisplatin resistance and tumor stem cell-like properties in endometrial carcinoma cells.
Lin TC; Wang KH; Chuang KH; Kao AP; Kuo TC
Taiwan J Obstet Gynecol; 2023 Jan; 62(1):16-21. PubMed ID: 36720532
[TBL] [Abstract][Full Text] [Related]
13. Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells.
Bonavida B; Tsuchitani T; Zighelboim J; Berek JS
Gynecol Oncol; 1990 Sep; 38(3):333-9. PubMed ID: 2227544
[TBL] [Abstract][Full Text] [Related]
14. Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a.
Ma AY; Xie SW; Zhou JY; Zhu Y
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640224
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic Essential Oils from Eryngium campestre and Eryngium amethystinum (Apiaceae) Growing in Central Italy.
Cianfaglione K; Blomme EE; Quassinti L; Bramucci M; Lupidi G; Dall'Acqua S; Maggi F
Chem Biodivers; 2017 Jul; 14(7):. PubMed ID: 28332760
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; D'Alessandro N
Cancer Lett; 2005 Jun; 224(1):53-65. PubMed ID: 15911101
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of endometrial cancer cells from primary human tumor samples to new potential anticancer peptide lactaptin.
Koval OA; Sakaeva GR; Fomin AS; Nushtaeva AA; Semenov DV; Kuligina EV; Gulyaeva LF; Gerasimov AV; Richter VA
J Cancer Res Ther; 2015; 11(2):345-51. PubMed ID: 26148598
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic and apoptogenic effects of
Shaabani M; Mousavi SH; Azizi M; Ashraf Jafari A
Avicenna J Phytomed; 2020; 10(6):594-603. PubMed ID: 33299816
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibitory effects of Phyllanthus niruri extracts in combination with cisplatin on cancer cell lines.
Araújo RF; Soares LA; da Costa Porto CR; de Aquino RG; Guedes HG; Petrovick PR; de Souza TP; Araújo AA; Guerra GC
World J Gastroenterol; 2012 Aug; 18(31):4162-6168. PubMed ID: 22919249
[TBL] [Abstract][Full Text] [Related]
20. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
